Ideaya Biosciences (IDYA) PT Lowered to $20 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Price: $32.88 --0%
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 14
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 14
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler lowered the price target on Ideaya Biosciences (NASDAQ: IDYA) to $20.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens - Doctor Feedback for Darovasertib Positive
- Centuri Holdings Inc (CTRI) PT Lowered to $28 at Wells Fargo
- Cadence Designs (CDNS) PT Raised to $430 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
